معرفی
Maria Lukács Krogager is a Doctor affiliated with the Faculty of Health Sciences at Aalborg University and North Jutland Regional Hospital in Denmark. She conducts research primarily focused on cardiovascular medicine, with special emphasis on potassium metabolism and its relationship to heart conditions.
Dr. Krogager's research interests center around the complex relationship between electrolyte balance, particularly potassium levels, and cardiovascular outcomes. Her work extensively utilizes Danish nationwide registry data to investigate how serum potassium levels affect mortality risk in patients with hypertension, heart failure, and other cardiovascular conditions. She has made significant contributions to understanding the risks associated with both hypokalemia and hyperkalemia in various patient populations, including those with diabetes and those undergoing cardiac procedures. Her research methodology primarily involves large-scale cohort analyses and register-based studies, leveraging Denmark's comprehensive healthcare registries to generate robust epidemiological evidence.
Analysis of Dr. Krogager's publication record reveals a consistent focus on the intersection of electrolyte management and cardiovascular outcomes. Her most recent work has expanded into examining the relationship between diabetes and heart failure following coronary artery bypass grafting, as well as investigating autoimmune complications following myocarditis. A distinctive feature of her research program is the systematic examination of potassium-related risks across multiple patient populations, creating a comprehensive picture of how electrolyte imbalances contribute to adverse outcomes in cardiovascular disease.
Dr. Krogager has established herself as a productive researcher in cardiovascular epidemiology, with numerous publications in high-impact journals including the European Heart Journal. Her work has garnered significant attention in the medical community, with several papers receiving over 100 citations. She collaborates extensively with other researchers at Aalborg University and across Danish medical institutions, contributing to a robust research network focused on improving cardiovascular outcomes through better understanding of risk factors and treatment effects.
